Pan Drugs Ltd. - Research Center
531440 PANDRUG Group (P) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 15 | Mar ' 15 | Sep ' 14 | Mar ' 04 | Sep ' 03 | |
|---|---|---|---|---|---|
| Sales | 10.59 | 14.46 | 20.90 | 10.79 | 5.09 |
| Operating profit | 0.28 | 0.47 | 0.32 | -0.71 | 0.09 |
| Interest | 0.01 | 0.02 | 0.02 | - | 0.76 |
| Gross profit | 0.35 | 0.83 | 0.33 | -0.43 | -0.66 |
| EPS (Rs) | -0.07 | -0.26 | 0.08 | -1.94 | -2.65 |
Half yearly
results in details
| Sep ' 15 | Mar ' 15 | Sep ' 14 | Mar ' 04 | Sep ' 03 | |
|---|---|---|---|---|---|
| Other income | 0.08 | 0.38 | 0.04 | 0.28 | 0.01 |
| Stock adjustment | -0.31 | -0.55 | 0.61 | 0.34 | -1.64 |
| Raw material | 8.06 | 11.21 | 17.06 | 3.50 | 2.66 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 1.25 | 1.37 | 1.15 | 0.17 | 0.10 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1.32 | 1.97 | 1.76 | 7.49 | 3.89 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.37 | 0.91 | 0.31 | 0.18 | 0.18 |
| Taxation | - | - | - | - | - |
| Net profit / loss | -0.02 | -0.08 | 0.02 | -0.61 | -0.83 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 3.14 | 3.14 | 3.14 | 3.14 | 3.14 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | 20.61 | 20.61 | 20.61 | 16.02 | 16.02 |
| Agg.of non promotoholding (%) | 65.57 | 65.57 | 65.57 | 50.95 | 50.95 |
| OPM (%) | 2.63 | 3.22 | 1.52 | -6.58 | 1.77 |
| GPM (%) | 3.29 | 5.57 | 1.58 | -3.90 | -12.83 |
| NPM (%) | -0.22 | -0.56 | 0.11 | -5.52 | -16.33 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis